access+affordability

Chimeric Antigen Receptor (CAR) T-cell therapy is a relatively new and powerful cancer treatment that greatly benefits patients, including the Medicare population.

Statement by Ursula von der Leyen, President of the European Commission, calling on drug industry to re-organize supply chain and production lines.

On the first step toward escaping the pricing maze, Professor Salvare takes Pete Paystoomuch down the path of drug innovation, showing him why drug prices are initially more expensive – to cover all of the costs that go into developing a new medicine.

Eli Lilly and Bristol Myers Squibb roll out new plans to offer drugs at low cost or even for free.

Drugmaker Eli Lilly said it has capped the out-of-pocket cost for insulin to $35 per month to help diabetes patients across the U.S.

The Cancer Research UK (CRUK) funds nearly half of the cancer research in the country.

Microsoft co-founder Bill Gates has spent the last few decades working to improve global health through his philanthropic organization, the Bill & Melinda Gates Foundation.

Nearly half the supply of hydroxychloroquine to the U.S. comes from makers in India.

India, the world’s main supplier of generic drugs, said on Tuesday it will allow limited exports of the anti-malaria drug hydroxychloroquine that U.S. President Donald Trump has touted as a potential weapon in the fight against the coronavirus.

How will pharma price their products against COVID-19?

Pharma companies are rushing to be the first to develop a vaccine for COVID-19. No sooner did they begin than officials and the public began wondering, “how will we pay for these treatments?”

Some of the largest payers are covering both coronavirus testing and treatment to deliver broader access to care for those affected by the coronavirus.

There’s no conclusive scientific evidence that hydroxychloroquine can treat the infection from the novel coronavirus.